Home
Godavari Drugs Ltd Share Price History
Godavari Drugs Ltd
BSE : 21 Feb, 2025
87.452.0 (2.3%)
Prev Close
85.4
Open Price
86.8
Bid Price (QTY)
-
Offer Price (QTY)
-
Volume
9572
Today's High / Low
93.0 / 86.3
52 WK High / Low
155.0 / 81.2
Market Price of Godavari Drugs Ltd
1M
1Y
3Y
5Y
Monitoring Godavari Drugs Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.
History Market Price
| Date | Price | Open | High | Low |
|---|
Returns Comparison
1W
1M
3M
6M
1Y
3Y
5Y
10Y
Growth Parameters
| Parameter |  2017 |
|---|---|
| Sales (Cr.) | 83 |
| Sales YoY Gr. | - |
| Adj EPS | 2.4 |
| YoY Gr. | - |
| Net Profit (Cr.) | 2 |
| BVPS | 21.54 |
Key Financial Parameters
| Parameter | 2017 |
|---|---|
| Return on Capital Emp. % | 14.97 |
| Op. Profit Mgn % | 7.26 |
| Net Profit Mgn % | 2.18 |
| Debt to Equity % | 1.02 |
Latest Shareholding
Promoters Holdings Over Time
About Godavari Drugs Ltd
- Godavari Drugs Limited is engaged in the business of manufacture of Active Pharmaceutical Ingredients (API) and drug intermediates, through its manufacturing facility at Nanded, Maharashtra, India..
- Sulphamethoxazole (SMX), the main product of the company, is a widely used anti-bacterial drug enjoying good export demand. The Company incorporated in December, 1987, has multiple production blocks for API's, drug intermediates and fine chemicals. The company has expanded its SMX capacity from 540 tpa to 720 tpa, integrating backward into the manufacture of drug intermediates, sulphamethoxide (cap.: 450 tpa) and diethyl oxalate, DEO (cap.: 750 tpa), and diversifying into the manufacture of trimetroprim, TMP (cap.: 144 tpa). The diversification into TMP is beneficial as SMX and TMP are used in combination to treat a wide variety of infections.
Popular Search
FAQs for Godavari Drugs Ltd Share Price History
What are the key events that typically impact Godavari Drugs Ltd's share price history?
Key events that impact Godavari Drugs Ltd’s share price history include quarterly earnings releases, product launches, leadership changes, economic policies, and geopolitical developments.
How do stock splits affect Godavari Drugs Ltd's share price history?
Stock splits reduce the nominal price of Godavari Drugs Ltd's shares by increasing the number of outstanding shares, which typically makes the stock more accessible to a broader range of investors. Although the total market value of the company remains unchanged after the split, the split can affect investor perception and liquidity, potentially influencing the share price in the longer term.
How do dividends impact the share price history of Godavari Drugs Ltd?
Dividends can influence Godavari Drugs Ltd's share price history by typically causing a temporary dip on the ex-dividend date, as the stock price often adjusts to reflect the dividend payout. Over time, the impact of dividends on the share price may be offset by the company's overall financial performance and market conditions.
How do corporate announcements affect Godavari Drugs Ltd’s share price history?
Corporate announcements such as mergers, acquisitions, or strategic shifts can lead to significant price changes. Any optimistic development news on Godavari Drugs Ltd generally boosts the company’s share price, whereas negative news can lead to a decline in share price.
How can I use technical analysis to understand Godavari Drugs Ltd’s share price history?
To understand Godavari Drugs Ltd’s share price history using technical analysis, examine charts for patterns such as trends, support, and resistance levels, and apply indicators like moving averages or Relative Strength Index (RSI) to gauge potential future movements. Analyze historical data to identify recurring trends and signals that might suggest how the share price could behave under similar conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
